Artificial Intelligence for Diabetes Case Management: The Intersection of Physical and Mental Health

TL;DR

This study develops an AI framework that integrates claims, social determinants, and clinical notes to predict diabetes complications and identify patient clusters, aiming to improve targeted case management and reduce healthcare costs.

Contribution

The paper introduces a novel AI approach combining multiple data sources and machine learning techniques to identify patient clusters and predict complications in diabetes care.

Findings

Predicts diabetes complications with 83.5% accuracy using claims and social data.

Reveals meaningful patient clusters related to mental health and complications.

Reduces screening population by 85% through targeted strategies.

Abstract

Diabetes is a major public health problem in the United States, affecting roughly 30 million people. Diabetes complications, along with the mental health comorbidities that often co-occur with them, are major drivers of high healthcare costs, poor outcomes, and reduced treatment adherence in diabetes. Here, we evaluate in a large state-wide population whether we can use artificial intelligence (AI) techniques to identify clusters of patient trajectories within the broader diabetes population in order to create cost-effective, narrowly-focused case management intervention strategies to reduce development of complications. This approach combined data from: 1) claims, 2) case management notes, and 3) social determinants of health from ~300,000 real patients between 2014 and 2016. We categorized complications as five types: Cardiovascular, Neuropathy, Opthalmic, Renal, and Other. Modeling was performed combining a variety of machine learning algorithms, including supervised classification, unsupervised clustering, natural language processing of unstructured care notes, and feature engineering. The results showed that we can predict development of diabetes complications roughly 83.5% of the time using claims data or social determinants of health data. They also showed we can reveal meaningful clusters in the patient population related to complications and mental health that can be used to cost-effective screening program, reducing the number of patients to be screened down by 85%. This study outlines creation of an AI framework to develop protocols to better address mental health comorbidities that lead to complications development in the diabetes population. Future work is described that outlines potential lines of research and the need for better addressing the 'people side' of the equation.